Dr. Dean Hartley presents "Latest Developments in Alzheimer's Research"
Dean M. Hartley, Ph.D., Director of Science Initiatives for the Alzheimer's Association, visited Spokane on June 24, 2014, to discuss the latest developments in Alzheimer's research.
In addition to presenting an overview of current research, Dr. Hartley discussed several major Alzheimer's prevention trials that are starting up. He also discussed PET amyloid imaging and related early-detection issues; similarities and differences between Alzheimer's disease and Down Syndrome, and the Association's collaboration with the Global Down Syndrome Foundation to fund research grants that cover both diseases; Alzheimer's biomarkers; and the movement toward earlier detection and earlier intervention.
Dr. Hartley has a leadership role in the Association’s research and scientific fundraising initiatives, primarily by effectively communicating the goals and achievements of the Alzheimer’s Association research and science program to a wide range of audiences. In addition, Dr. Hartley represents the Association’s science division, both internally and externally, and works with the division’s senior leaders on public relations activities and scientific workgroups to advance the Association’s science agenda.
Before coming to the Alzheimer’s Association, Dr. Hartley was an Associate Professor in the Department of Neurological Sciences and conducted research at Rush University Medical Center in Chicago. Prior to this, he was Assistant Professor in the Department of Neurology at Harvard Medical School and conducted research at Brigham and Women’s Hospital, Boston.
Dr. Hartley completed postdoctoral fellowships in the Departments of Medicine, Genetics, and Neurology at Harvard Medical School after completing his Ph.D. in Neuroscience at Stanford University in 1991. He has a Master’s Degree in Environmental Toxicology from the University of Illinois.